- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06283680
The Effect of Nutrition and BMI on on Lung Capacity, Functional Capacity and Mortality in End-Stage Lung Patients
April 5, 2024 updated by: Aylin Seylam Küşümler
The Effect of Nutritional Status and Body Mass Index on Lung Capacity, Functional Capacity and Mortality in End-Stage Lung Patients on the Lung Transplant List
The aim of this study was to investigate the effect of nutritional risk index, BMI and body fat, muscle ratio on functional capacity, lung capacity, exercise capacity index, all-cause mortality, post-transplant intensive care unit stay and survival time in end-stage lung patients on the lung transplant list.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
This study aimed to determine the nutritional status of patients awaiting lung transplantation and examine the effects of nutritional status, immunonutrition use, and BMI on lung capacity, mortality, and health status after lung transplantation.
The study was designed in two different periods.
The first period was a retrospective descriptive study.
During this study, we will examine the retrospective nutritional status of patients who are waiting for lung transplantation, those who exited while on the list, or those who have received lung transplantation.
In the second phase, we will conduct face-to-face interviews with patients on the lung transplant list, take bioelectrical impedance analyses (BIA), and record 24-hour food consumption to examine their detailed nutritional status.
Study Type
Observational
Enrollment (Estimated)
213
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey
- OkanU
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
The population of the study consisted of patients who applied to the lung transplantation outpatient clinic at Koşuyolu High Specialised Training and Research Hospital between 2016 and 2022, were listed, were waiting on the list, died while on the list, and received lung transplantation, and met the inclusion criteria.
Description
Inclusion Criteria:
- End-stage lung disease
- To be on the Lung Transplant list.
- Being between the ages of 19-65
- Not having severe psychiatric illness
- Being fed orally
- Volunteering to participate in the study for Patients Waiting on the Transplant List
Exclusion Criteria:
- To be removed from the Lung Transplant List
- Being pregnant or lactating
- Severe psychiatric illness
- Peg or Jeg feeding (unable to feed orally)
- Missing data in the file
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Group 1
Ex patients on the lung transplant waiting list
|
Three different groups will be investigated with respect to the effect of NRI, BMI and body fat, muscle ratio on functional capacity, lung capacity, exercise capacity index, all-cause mortality, post-transplant intensive care unit stay and survival time in end-stage lung patients on the lung transplant list.
|
|
Group 2
Tansplant patients
|
Three different groups will be investigated with respect to the effect of NRI, BMI and body fat, muscle ratio on functional capacity, lung capacity, exercise capacity index, all-cause mortality, post-transplant intensive care unit stay and survival time in end-stage lung patients on the lung transplant list.
|
|
Group 3
Patients waiting on the current list
|
Three different groups will be investigated with respect to the effect of NRI, BMI and body fat, muscle ratio on functional capacity, lung capacity, exercise capacity index, all-cause mortality, post-transplant intensive care unit stay and survival time in end-stage lung patients on the lung transplant list.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
BMI
Time Frame: For one month period
|
BMI values are evaluated for the patients for patients waiting on the transplant list, transplanted and exited.
|
For one month period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Nutrition risk index
Time Frame: For one month period.
|
BMI values are evaluated for the patients for patients waiting on the transplant list, transplanted and exited.
|
For one month period.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 28, 2023
Primary Completion (Estimated)
April 28, 2024
Study Completion (Estimated)
May 31, 2024
Study Registration Dates
First Submitted
February 21, 2024
First Submitted That Met QC Criteria
February 21, 2024
First Posted (Actual)
February 28, 2024
Study Record Updates
Last Update Posted (Actual)
April 8, 2024
Last Update Submitted That Met QC Criteria
April 5, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 2024 (Other Grant/Funding Number: Rome Foundation)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Transplant
-
Hopital FochRecruitingLung Transplant Rejection | Lung Transplant Failure | Lung Transplant; Complications | Lung Transplant Failure and RejectionFrance
-
Lund University HospitalRecruitingLung Transplant Failure | Lung Transplant; ComplicationsSweden
-
Lund University HospitalCompletedLung Transplant Failure | Lung Transplant; ComplicationsSweden
-
University of SaskatchewanSaskatchewan Health Research Foundation; Lung Association of SaskatchewanCompletedPharmacokinetics | Lung Transplant | Kidney TransplantCanada
-
Hopital FochCompletedParenthood Status | Transplant Lung | Transplant KidneyFrance
-
Duke UniversityUniversity of Pennsylvania; National Heart, Lung, and Blood Institute (NHLBI)RecruitingLung Transplant Rejection | Lung Transplant Failure | Lung Transplant; Complications | Lung Transplant; Infection or InflammationUnited States, Canada
-
Stanford UniversityKaiser Foundation Research InstituteCompletedLung Transplant Rejection | Cardiac Transplant RejectionUnited States
-
Mayo ClinicNational Heart, Lung, and Blood Institute (NHLBI)CompletedLung Transplant | Self-management | Heart TransplantUnited States
-
University of Sao Paulo General HospitalRecruiting
-
University of ZurichCompletedLung Transplant Rejection | Lung Transplant Failure and RejectionSwitzerland
Clinical Trials on Lung transplantation
-
Hospices Civils de LyonRecruiting
-
Northwestern UniversityRecruitingLung Cancer | Lung Transplant | Bilateral CancerUnited States
-
University Health Network, TorontoMayo Clinic; Medical University of Vienna; University of Miami; Centre hospitalier... and other collaboratorsActive, not recruitingLung Transplant | Organ PreservationUnited States, Spain, Belgium, Switzerland, Austria, Canada, Australia, France
-
Policlinico HospitalCompletedCystic FibrosisItaly
-
Kyoto University, Graduate School of MedicineMinistry of Health, Labour and Welfare, JapanUnknown
-
Hospices Civils de LyonCompletedCystic Fibrosis | Pulmonary FailureFrance
-
Rigshospitalet, DenmarkUnknown
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Hopital FochCompletedTransplantation, Lung | Transplant Dysfunction
-
Hopital FochCompletedPulmonary Insufficiency | MucoviscidosisFrance